Transfusion and Apheresis Science
Volume 42, Issue 1 , Pages 71-82 , February 2010

Bacterial contamination of platelets

  • Elizabeth L. Palavecino

      Affiliations

    • Department of Pathology, Wake Forest University Medical School, Winston-Salem, NC, United States
    • Corresponding Author InformationCorresponding author. Tel.: +1 336 716 2638; fax: +1 336 716 7595.
    • ,
  • Roslyn A. Yomtovian

      Affiliations

    • Department of Pathology, Case Western Reserve University, Cleveland, OH, United States
    • Quality Scholar Fellowship Program, Louis Stokes Veterans Administration Medical Center, Cleveland, OH, United States
    • ,
  • Michael R. Jacobs

      Affiliations

    • Department of Pathology, Case Western Reserve University, Cleveland, OH, United States
    • University Hospitals Case Medical Center, Cleveland, OH, United States

References 

  1. Jacobs MR, Palavecino E, Yomtovian R. Don’t bug me: the problem of bacterial contamination of blood components – challenges and solutions. Transfusion. 2001;41:1331–1334
  2. Brecher ME, Hay SN. Bacterial contamination of blood components. Clin Microbiol Rev. 2005;18:195–204
  3. Blajchman MA, Beckers EA, Dickmeiss E, Lin L, Moore G, Muylle L. Bacterial detection of platelets: current problems and possible resolutions. Transfus Med Rev. 2005;19:259–272
  4. Yomtovian RA, Palavecino EL, Dysktra AH, et al. Evolution of surveillance methods for detection of bacterial contamination of platelets in a university hospital, 1991 through 2004. Transfusion. 2006;46:719–730
  5. Whitaker BI, Sullivan M. The 2005 nationwide blood collection and utilization survey report. Department of Health and Human Services. Available at <http://www.aabb.org/apps/docs/05nbcusrpt.pdf>; 2005 [accessed 09.09.09].
  6. Eder AF, Kennedy JM, Dy BA, et al. Bacterial screening of apheresis platelets and the residual risk of septic transfusion reactions: the American Red Cross experience (2004–2006). Transfusion. 2007;47:1134–1142
  7. Schrezenmeier H, Walther-Wenke G, Muller TH, et al. Bacterial contamination of platelet concentrates: results of a prospective multicenter study comparing pooled whole blood-derived platelets and apheresis platelets. Transfusion. 2007;47:644–652
  8. Murphy WG, Foley M, Doherty C, et al. Screening platelet concentrates for bacterial contamination: low numbers of bacteria and slow growth in contaminated units mandate an alternative approach to product safety. Vox Sang. 2008;95:13–19
  9. Dodd RY, Notari EPt, Stramer SL. Current prevalence and incidence of infectious disease markers and estimated window-period risk in the American Red Cross blood donor population. Transfusion. 2002;42:975–979
  10. Busch MP, Kleinman SH, Nemo GJ. Current and emerging infectious risks of blood transfusions. JAMA. 2003;289:959–962
  11. Stramer SL, Glynn SA, Kleinman SH, et al. Detection of HIV-1 and HCV infections among antibody-negative blood donors by nucleic acid-amplification testing. N Engl J Med. 2004;351:760–768
  12. Yomtovian R, Brecher ME. pH and glucose testing of single-donor apheresis platelets should be discontinued in favor of a more sensitive detection method. Transfusion. 2005;45:646–648
  13. Buchholz DH, Young VM, Friedman NR, Reilly JA, Mardiney MR. Detection and quantitation of bacteria in platelet products stored at ambient temperature. Transfusion. 1973;13:268–275
  14. Benjamin RJ, Kline L, Dy BA, et al. Bacterial contamination of whole-blood-derived platelets: the introduction of sample diversion and prestorage pooling with culture testing in the American Red Cross. Transfusion. 2008;48:2348–2355
  15. Perez P, Salmi LR, Follea G, et al. Determinants of transfusion-associated bacterial contamination: results of the French BACTHEM Case-Control Study. Transfusion. 2001;41:862–872
  16. Stainsby D, Williamson L, Jones H, Cohen H. Six-years of shot reporting – its influence on UK blood safety. Transfus Apheresis Sci. 2004;31:123–131
  17. Dumont LJ. Gambro/Fenwal PASSPORT post marketing study – 7 day platelets; FDA Blood Products Advisory Committee, Rockville, MD; 2008 <http://www.fda.gov/ohrms/dockets/AC/08/slides/2008-4355S1-7.ppt>.
  18. Eder AF, Kennedy JM, Dy BA, et al. Limiting and detecting bacterial contamination of apheresis platelets: inlet-line diversion and increased culture volume improve component safety. Transfusion. 2009;49:1554–1563
  19. Ness P, Braine H, King K, et al. Single-donor platelets reduce the risk of septic platelet transfusion reactions. Transfusion. 2001;41:857–861
  20. Blajchman MA, Sarwal S, Loeb M. A second example of a transfusion-associated septic reaction associated with Clostridium perfringens. Transfusion. 2001;41:427–428
  21. McDonald CP, Hartley S, Orchard K, et al. Fatal Clostridium perfringens sepsis from a pooled platelet transfusion. Transfus Med. 1998;8:19–22
  22. Niu MT, Knippen M, Simmons L, Holness LG. Transfusion-transmitted Klebsiella pneumoniae fatalities, 1995 to 2004. Transfus Med Rev. 2006;20:149–157
  23. Roth VR, Kuehnert MJ, Haley NR, et al. Evaluation of a reporting system for bacterial contamination of blood components in the United States. Transfusion. 2001;41:1486–1492
  24. Bacterial contamination of platelet pools – Ohio, 1991. MMWR Morb Mortal Wkly Rep 1992;41:36–7.
  25. Zaza S, Tokars JI, Yomtovian R, et al. Bacterial contamination of platelets at a university hospital: increased identification due to intensified surveillance. Infect Control Hosp Epidemiol. 1994;15:82–87
  26. Sapatnekar S, Wood EM, Miller JP, et al. Methicillin-resistant Staphylococcus aureus sepsis associated with the transfusion of contaminated platelets: a case report. Transfusion. 2001;41:1426–1430
  27. Jacobs MR, Good CE, Lazarus HM, Yomtovian RA. Relationship between bacterial load, species virulence, and transfusion reaction with transfusion of bacterially contaminated platelets. Clin Infect Dis. 2008;46:1214–1220
  28. McDonald CP, Lowe P, Roy A, et al. Evaluation of donor arm disinfection techniques. Vox Sang. 2001;80:135–1341
  29. Satake M, Mitani T, Oikawa S, et al. Frequency of bacterial contamination of platelet concentrates before and after introduction of diversion method in Japan. Transfusion 2009.
  30. Dykstra A, Hoeltge G, Jacobs M, Miller J, Domen R, Yomtovian R. Platelet bacterial contamination (PBC) rate is surveillance method (SM) dependent. Transfusion. 1998;38:104S
  31. Palavecino EL, Yomtovian RA, Jacobs MR. Detecting bacterial contamination in platelet products. Clin Lab. 2006;52:443–456
  32. AABB. Bulletin 03-12: further guidance on methods to detect bacterial contamination of platelet components. AABB, Bethesda, MD; 2003.
  33. AABB. Bulletin 04-07: actions following an initial positive test for possible bacterial contamination of a platelet unit. AABB, Bethesda, MD; 2004.
  34. AABB. Bulletin 05-02. Guidance on management of blood and platelet donors with positive or abnormal results on bacterial contamination tests. AABB, Bethesda, MD; 2004.
  35. Benjamin RJ, Wagner SJ. The residual risk of sepsis: modeling the effect of concentration on bacterial detection in two-bottle culture systems and an estimation of false-negative culture rates. Transfusion. 2007;47:1381–1389
  36. Nanua S, Weber C, Isgriggs L, Dunne WM. Performance evaluation of the VersaTREK blood culture system for quality control testing of platelet units. J Clin Microbiol. 2009;47:817–818
  37. Dunne WM, Case LK, Isgriggs L, Lublin DM. In-house validation of the BACTEC 9240 blood culture system for detection of bacterial contamination in platelet concentrates. Transfusion. 2005;45:1138–1142
  38. Savini V, Balbinot A, Giancola R, et al. Comparison between the BACTEC 9240 and the Pall eBDS system for detection of bacterial platelet concentrate contamination. Transfusion 2009.
  39. Jacobs MR, Bajaksouzian S, Windau A, Palavecino EL, Yomtovian R. Evaluation of the Scansystem method for detection of bacterially contaminated platelets. Transfusion. 2005;45:265–269
  40. Platelet PGD. Test product insert, Verax Biomedical Incorporated, Worcester, MA.
  41. http://www.fda.gov/downloads/BiologicsBloodVaccines/BloodBloodProducts/ApprovedProducts/SubstantiallyEquivalent510kDeviceInformation/UCM190256.pdf. Accessed Nov 16, 2009.
  42. Yomtovian R, Lazarus HM, Goodnough LT, Hirschler NV, Morrissey AM, Jacobs MR. A prospective microbiologic surveillance program to detect and prevent the transfusion of bacterially contaminated platelets. Transfusion. 1993;33:902–909
  43. Fang CT, Chambers LA, Kennedy J, et al. Detection of bacterial contamination in apheresis platelet products: American Red Cross experience, 2004. Transfusion. 2005;45:1845–1852
  44. Hundhausen T, Muller TH. False-positive alarms for bacterial screening of platelet concentrates with BacT/ALERT new-generation plastic bottles: a multicenter pilot study. Transfusion. 2005;45:1267–1274
  45. Castro E, Bueno JL, Barea L, Gonzalez R. Feasibility of implementing an automated culture system for bacteria screening in platelets in the blood bank routine. Transfus Med. 2005;15:185–195
  46. te Boekhorst PA, Beckers EA, Vos MC, Vermeij H, van Rhenen DJ. Clinical significance of bacteriologic screening in platelet concentrates. Transfusion. 2005;45:514–519
  47. Larsen CP, Ezligini F, Hermansen NO, Kjeldsen-Kragh J. Six years’ experience of using the BacT/ALERT system to screen all platelet concentrates, and additional testing of outdated platelet concentrates to estimate the frequency of false-negative results. Vox Sang. 2005;88:93–97
  48. Rock G, Neurath D, Toye B, et al. The use of a bacteria detection system to evaluate bacterial contamination in PLT concentrates. Transfusion. 2004;44:337–342
  49. Werch JB, Mhawech P, Stager CE, Banez EI, Lichtiger B. Detecting bacteria in platelet concentrates by use of reagent strips. Transfusion. 2002;42:1027–1031
  50. Trampuz A, Salzmann S, Antheaume J, Daniels AU. Microcalorimetry: a novel method for detection of microbial contamination in platelet products. Transfusion. 2007;47:1643–1650
  51. Rotman B, Cote MA. Application of a real-time biosensor to detect bacteria in platelet concentrates. Biochem Biophys Res Commun. 2003;300:197–200
  52. Dreier J, Stormer M, Kleesiek K. Two novel real-time reverse transcriptase PCR assays for rapid detection of bacterial contamination in platelet concentrates. J Clin Microbiol. 2004;42:4759–4764
  53. Dreier J, Vollmer T, Kleesiek K. Novel flow cytometry-based screening for bacterial contamination of donor platelet preparations compared with other rapid screening methods. Clin Chem 2009.
  54. Rieder R, Zavizion B. Monitoring the physiologic stress response: a novel biophysical approach for the rapid detection of bacteria in platelet concentrate. Transfusion. 2008;48:2596–2605
  55. Immunetics. <http://www.immunetics.com/about.html>.
  56. Kuehnert MJ, Roth VR, Haley NR, et al. Transfusion-transmitted bacterial infection in the United States, 1998 through 2000. Transfusion. 2001;41:1493–1499

PII: S1473-0502(09)00177-3

doi: 10.1016/j.transci.2009.10.009

Transfusion and Apheresis Science
Volume 42, Issue 1 , Pages 71-82 , February 2010

Article Tools

* Image Usage & Resolution